The Boston Investment Conference has fueled a decade of life-changing innovations at Boston Children’s. Thank you for your partnership.
2013 | Infant Brain Monitoring, Ellen Grant, MD
BabyMEG safely and accurately monitors infant brain activity.
Today: Physicians design improved seizure-treatment plans for babies.
2014 | Surgical Simulation, Peter Weinstock, MD, PhD
3D models of each patient’s unique physiology help neurosurgeons tackle the most complex procedures.
Today: Augmented and virtual reality tools expand our global reach.
2015 | Cancer Diagnosis, Mark Fleming, MD, DPhil
The Laboratory for Molecular Pediatric Pathology deploys next-generation sequencing technology.
Today: Experts accurately diagnose cancers and detect cancer-driving gene fusions.
2016 | Mitochondrial Therapy, James McCully, PhD
Healthy mitochondria restore damaged heart tissue.
Today: Mitochondrial therapy is tested in cancer, heart attack and diabetes.
2017 | Blood Stem Cells, Len Zon, MD
Patient-specific blood stem cells are created to treat rare disorders.
Today: Novel drug candidates are screened to accelerate blood stem cell production and bring them to the clinic.
2018 | Gene Therapy, Alessandra Biffi, MD
Stem cells delivered directly to the brain accelerate production of genetically corrected cells.
Today: New treatments for neurological disorders promise to change lives of millions worldwide.
2019 | Customized Therapy, Timothy Yu, MD, PhD
A therapy is created specifically for one child with a rare disease.
Today: Revolutionary thinking about a tailored treatment for a single patient creates hope for thousands worldwide.
2020 | COVID-19 Vaccine, Ofer Levy, MD, PhD
Researchers seek to optimize a coronavirus vaccine for older adults.
Today: Vaccine manufacturers adopt the basic science and advance projects to clinical trials.
2021 | Epilepsy Genetics, Ann Poduri, MD, MPH
Zebrafish models help scientists assess epilepsy drug candidates.
Today: Patients are matched with therapies that target the underlying cause of their epilepsy.
2022 | CAR-T Therapy, Roberto Chiarle, MD
Human trials will test powerful personalized treatment for deadly childhood cancer.